CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells.
作者:
主题词
动物(Animals);抗原, CD34(Antigens, CD34);细胞分化(Cell Differentiation);超声心动描记术(Echocardiography);女(雌)性(Female);出血(Hemorrhage);人类(Humans);单核细胞(Monocytes);心肌梗死(Myocardial Infarction);心肌(Myocardium);新生血管化, 生理性(Neovascularization, Physiologic);手术后期间(Postoperative Period);大鼠(Rats);大鼠, 裸(Rats, Nude);大鼠, Sprague-Dawley(Rats, Sprague-Dawley);疾病严重程度指数(Severity of Illness Index);时间因素(Time Factors);移植, 异种(Transplantation, Heterologous);心室功能, 左(Ventricular Function, Left);心室重构(Ventricular Remodeling)
DOI
10.1161/CIRCULATIONAHA.106.644518
PMID
17075009
发布时间
2022-03-09
- 浏览57

Circulation
2163-9页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文